Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Addict Med. 2021 Apr 1;15(2):143–149. doi: 10.1097/ADM.0000000000000719

Table 1.

Prevalence of Opioid Use Disorder and Receipt of Medications by Vulnerable Groups and Other Patient Characteristics in the United States Veterans Health Administration in Fiscal Year 2017

Prevalence of Opioid Use Disordera p Prevalence of Receipt of Medicationsb p
N (%) N (%)
Overall 53,568 (2%) 22,124 (41%)
Gender < .001 0.702
 Women 3,814 (1%) 1,564 (41%)
 Men 49,754 (2%) 20,560 (41%)
Age < .001 < .0001
 <35 10,569 (3%) 5,585 (53%)
 35–44 7,436 (2%) 3,789 (51%)
 45–54 7,980 (2%) 3,215 (40%)
 55+ 27,583 (1%) 9,535 (35%)
Race/Ethnicity < .001 < .0001
 American Indian/Alaskan Native 533 (2%) 194 (36%)
 Asian 528 (1%) 204 (39%)
 Black 10,568 (2%) 4,150 (39%)
 Hispanic 2,964 (1%) 1,224 (41%)
 White 36,864 (2%) 15,552 (42%)
Residence < .001 < .0001
 Rural 15,466 (2%) 5,649 (37%)
 Urban 37,124 (4%) 16,141 (43%)
Homelessness < .001 < .0001
 Homeless 22,982 (10%) 10,083 (35%)
 Housed 30,586 (2%) 12,041 (49%)
Justice status < .001 < .0001
 Justice-involved 7,672 (10%) 3,508 (46%)
 Not justice-involved 45,896 (2%) 18,616 (41%)
a

Prevalence of opioid use disorder was calculated as the number of patients diagnosed with opioid use disorder divided by the total number of patients, separately by each characteristic.

b

Prevalence of receipt was calculated as the number of patients who received medications for opioid use disorder divided by the number of patients diagnosed with opioid use disorder, separately for each characteristic.